Pharma Industrial India

Dear Readers, Pharma Industrial India Magazine is happy to share its latest work i.e January-February 2025 issue with you. The issue brings standalone thought leadership from: Shoeb Kurawadwala, Founder and Managing Director, CN Water Systems; Bernhard Meir, Head of Continuous Manufacturing Activities, Gericke Group; Hartmut vom Bey, VP- Sales & Technology, Gerteis Maschinen + Processengineering AG; Bobby (Ananya) Abhishek Madaan, Director, Toshi Automation Solutions Limited; Rüdige (Rudi) Gall – General Manager / VP of Business Development, SC EMEA & Global Pharma, Germany; FALGUN JANI – Business Head, India, Freudenberg Medical; Chinmay Korad – Country Head, Pharma, Freudenberg Filtration Technologies India; Senthil Kumar, E – Sr. General Manager, Industrial Services Division, Freudenberg-NOK India The issue also offers insight into various sectors through thought pieces from various industry pioneers and accelerators: Manoj Kochar, President of ASPA ; Deepesh Upadhyay , Asst. Vice President, Delair India Pvt Ltd; Madhur Singhal, Managing Partner, Healthcare and Lifesciences; Ayush Singh, Practice Member, Healthcare and Lifesciences at Praxis Global Alliance; Vishal Goel, MD, Rx Propellant; Tiago Pires, Equipment & Facilities Division Manager, Telstar Portugal; Shlomo Sackstein, CEO Biopuremax Ltd.; Keren Zigelboim, BD, Biopuremax Ltd. Do read the Complete magazine here: https://lnkd.in/gNtizxNh We hope you enjoy our work!!! #biotech #india #healthcare #manufacturing #drugsanddevelopment #equipment #treatment #biotechnology #globalpharma #pharmaceuticals #PharmaIndustialIndia

ScreenPoint Medical will showcase innovative new capabilities of its industry leading Breast AI, #Transpara®, at the 2025 Society of Breast Imaging Symposium, April 24-27, 2025 (Booth #330). Nico Karssemeijer #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/d82DSB_A

STERILINE S.R.L. will participate for the first time in Pharmintech (Milan, 27-30 May 2025), displaying its solutions and innovations to the public. Ilaria Fumagalli Federico Fumagall #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dtCeWpRJ

Chime Biologics has announced a #strategiccooperationagreement with Polpharma Biologics to advance the end-to-end #development and #manufacture of a #biosimilarproduct for the global market. This partnership underscores Chime Biologics' commitment to delivering high-quality, cost-effective #biologics and further strengthening Chime Biologics' presence in Europe. Jimmy Wei #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dtXwys2r

Nikon CeLL innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation, has entered into a strategic #licensingagreement with RoosterBio Inc., Inc., a #stemcelltechnology company in the US. Tim Kelly #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dY9vPrMr

Terumo Neuro, a company in neurovascular innovation and a wholly owned subsidiary of Terumo Medical Corporation, has announced that its #CarotidStentSystem has received Premarket Approval (PMA) from the US Food and Drug Administration (FDA).  #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dPHzJtQp

LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and navigation, has announced the FDA clearance of its VERAFEYE™ Visualisation Platform.  Shephal Doshi MD Fionn Lahart #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dzh8NBUZ

A first in human proof of concept phase I clinical study of VAS-101 (Vasceptor®; topical curcumin gel) in sickle cell disease (SCD) is underway. The study is being conducted by the Foundation for Sickle Cell Disease Research (FSCDR) in Hollywood, Florida, under the supervision of the principal investigator, Dr. Gershwin Blyden. #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dtdeBbbn

Norgine has entered into a #definitiveagreement to #acquire theravia, enhancing its rare disease portfolio with established treatments in rare #haematology and #hepatology. Janneke van der Kamp Franck Hamalian #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dAVK8ZiD

Biocon Biologics has signed a settlement and #licenseagreement with Regeneron, paving the way to launch its interchangeable aflibercept biosimilar, YESAFILI, in the US by the second half of 2026. Shreehas Tambe #healthcare #PharmaIndustrialIndia Read More - https://lnkd.in/dRdkiVZ8